All In Biotech

Drug Trial Radar · NCT07216742

Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.

A Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of a Human Menopausal Gonadotropin in the Development of Multiple Follicles, Pregnancy, and Cumulative Live Birth as Part of an Assisted Reproductive Technology (ART) Cycle.

Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 659 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

659

Planned (sponsor's estimate)

Start

Nov 1, 2025

Primary completion

Nov 2028

Study completion Nov 2028

Sponsor

Lead sponsor
Granata Bio CorporationIndustry
Sponsor type
Industry
First posted
Oct 15, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years, up to 42 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this multicenter, randomized, placebo-controlled, double-blind clinical trial is toto evaluate the efficacy and safety of a human menopausal gonadotropin (hMG) in the development of multiple follicles, pregnancy, and cumulative live birth as part of an Assisted Reproductive Technology (ART) cycle in in women with a diagnosis of infertility.

Conditions

  • Infertility (IVF Patients)

Interventions

  • hMG subcutaneous injectionDrug

    daily subcutaneous injection

  • PlaceboDrug

    daily subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. cumulative live birth rateTime frame: 12 months

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • HRC Fertility

    Encino, California

  • Illume Fertility

    Norwalk, Connecticut

  • Reproductive Associates of Delaware CCRM

    Newark, Delaware

  • IVF Florida Reproductive Associates

    Margate, Florida

  • Center for Reproductive Medicine

    Winter Park, Florida

  • Reproductive Biology Associates (RBA)

    Atlanta, Georgia

  • Fertility Institute of Hawaii

    Honolulu, Hawaii

  • Fertility Centers of Illinois

    Chicago, Illinois

  • Shady Grove Fertility - Rockville

    Rockville, Maryland

  • Boston IVF

    Waltham, Massachusetts

  • Reach Fertility

    Charlotte, North Carolina

  • Carolina Conceptions

    Raleigh, North Carolina

  • Pinnacle Fertility - Oregon

    Portland, Oregon

  • Main Line Fertility

    Bryn Mawr, Pennsylvania

  • CARE Fertility

    Bedford, Texas

  • Shady Grove Houston

    Webster, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.